ProPhase Labs, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $90.0K | $678.0K | $1.6M | $9.1M | $8.4M | $6.8M | $434.0K | $1.6M |
| Accounts Receivable | $1.5M | $20.1M | $35.8M | $37.1M | $37.7M | $3.2M | $2.0M | $3.0M |
| Inventory | $70.0K | $1.1M | $2.3M | $4.0M | $4.6M | $3.0M | $1.5M | $1.9M |
| Total Current Assets | $3.2M | $30.6M | $47.6M | $60.8M | $61.3M | $15.9M | $9.9M | $18.2M |
| Property, Plant & Equipment | — | — | — | $7.3M | $5.9M | $3.6M | $2.3M | $2.5M |
| Goodwill | $4.0M | $5.2M | $5.2M | $5.7M | $5.7M | $901.0K | — | — |
| Intangible Assets (Excl. Goodwill) | $7.2M | $9.8M | $12.3M | $8.5M | $10.9M | $1.2M | — | — |
| Total Assets | $59.9M | $63.2M | $91.9M | $87.6M | $89.3M | $31.4M | $12.3M | $20.7M |
| Liabilities | ||||||||
| Accounts Payable | — | $13.7M | $8.6M | $5.9M | $7.0M | $3.8M | $432.0K | $437.0K |
| Total Current Liabilities | $53.1M | $32.1M | $20.9M | $16.1M | $15.5M | $6.3M | $933.0K | $4.2M |
| Long-Term Debt | — | — | $2.9M | $0 | $10.0M | $10.0M | — | — |
| Total Liabilities | $56.4M | $55.8M | $42.5M | $24.0M | $30.7M | $20.8M | $1.0M | $4.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-73.1M | $-58.4M | $-5.0M | $11.8M | $2.6M | $-3.6M | $-1.5M | $4.5M |
| Total Stockholders' Equity | $3.5M | $7.4M | $49.4M | $63.6M | $58.6M | $10.6M | $11.2M | $16.5M |